Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Income from Continuing Operations (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Income from Continuing Operations for 8 consecutive years, with 59069000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Income from Continuing Operations fell 16.16% year-over-year to 59069000.0, compared with a TTM value of 70967000.0 through Sep 2025, up 58.28%, and an annual FY2024 reading of 10614000.0, up 105.75% over the prior year.
  • Income from Continuing Operations was 59069000.0 for Q3 2025 at Bicycle Therapeutics, up from 78983000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 127839000.0 in Q4 2024 and bottomed at 78983000.0 in Q2 2025.
  • Average Income from Continuing Operations over 5 years is 29120842.11, with a median of 30002000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations soared 341.79% in 2024, then plummeted 128.72% in 2025.
  • Year by year, Income from Continuing Operations stood at 19086000.0 in 2021, then crashed by 57.19% to 30002000.0 in 2022, then crashed by 76.23% to 52872000.0 in 2023, then soared by 341.79% to 127839000.0 in 2024, then plummeted by 146.21% to 59069000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for BCYC at 59069000.0 in Q3 2025, 78983000.0 in Q2 2025, and 60754000.0 in Q1 2025.